missing translation for 'onlineSavingsMsg'
Learn More
Learn More
enQuireBio™ Recombinant Cytomegalovirus Uncharacterized protein UL131 Protein
A DNA sequence encoding the Human cytomegalovirus (strain AD169) (HHV-5) (Human herpesvirus 5) Uncharacterized protein UL131, was expressed in the hosts and tags indicated.
469.00€ - 3745.00€
Specifications
Name | Uncharacterized protein UL131 Protein |
---|---|
Regulatory Status | Research Use Only |
Endotoxin Concentration | Not determined. |
Gene Symbol | UL131 |
Protein Length | Full Length |
Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
---|---|---|---|---|---|---|---|---|---|
Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
16077340
|
enQuireBio™
QP7086-IV-100UG |
100 μg |
1705.00€
100µg |
Estimated Shipment: 17-06-2024
Log in to see stock. |
|||||
16027340
|
enQuireBio™
QP7086-200UG |
200 μg |
1765.00€
200µg |
Estimated Shipment: 17-06-2024
Log in to see stock. |
|||||
16037340
|
enQuireBio™
QP7086-500UG |
500 μg |
2360.00€
500µg |
Estimated Shipment: 17-06-2024
Log in to see stock. |
|||||
16017340
|
enQuireBio™
QP7086-1MG |
1 mg |
3745.00€
1mg |
Estimated Shipment: 17-06-2024
Log in to see stock. |
|||||
16087340
|
enQuireBio™
QP7086-IV-10UG |
10 μg |
This item has been discontinued and is no longer available. View the product for possible alternatives or contact our Technical Support team on +351 21 425 33 50 for assistance |
||||||
16097340
|
enQuireBio™
QP7086-IV-50UG |
50 μg |
This item has been discontinued and is no longer available. View the product for possible alternatives or contact our Technical Support team on +351 21 425 33 50 for assistance |
||||||
Specifications
Uncharacterized protein UL131 Protein | |
Not determined. | |
Full Length | |
Cytomegalovirus | |
His-SUMO | |
Tris-based buffer, 50% glycerol |
Research Use Only | |
UL131 | |
Recombinant Protein | |
E. coli | |
MCMMSHNKAF FLSLQHAAVS GVAVCLSVRR GAGSVPAGNR GKKTIITEYR ITGTRALARC PTKPVTSMWN SSWTSR | |
Greater than 80% as determined by SDS-PAGE. |